Case showing the Effect of Prostigmin on Myasthenia Gravis.
作者信息
Walker M B
出版信息
Proc R Soc Med. 1935 Apr;28(6):759-61. doi: 10.1177/003591573502800633.
Abstract
摘要
相似文献
1
Case showing the Effect of Prostigmin on Myasthenia Gravis.
Proc R Soc Med. 1935 Apr;28(6):759-61. doi: 10.1177/003591573502800633.
2
[Acute effect of prostigmin on lung function and breathing of patients with myasthenia gravis at rest and following ergometric exercise].
Respiration. 1987;52(1):59-68. doi: 10.1159/000195305.
3
The relative merits of prostigmin and mestinon in the treatment of myasthenia gravis.
J Egypt Med Assoc. 1956 Jun 21;39(3):240-51.
4
The contribution of Dr. Mary Walker towards myasthenia gravis and periodic paralysis whilst working in poor law hospitals in London.
J Hist Neurosci. 2005 Jun;14(2):121-37. doi: 10.1080/096470490512580.
5
Myasthenia Gravis: Its Treatment by a Combination of Prostigmin and Glycine-Ephedrine Therapy.
Glasgow Med J. 1937 Jul;128(1):7-11.
6
The Mary Walker effect: Mary Broadfoot Walker.
J R Coll Physicians Edinb. 2019 Sep;49(3):255-259. doi: 10.4997/JRCPE.2019.317.
7
CLINICAL OBSERVATIONS ON THE USE OF PROSTIGMIN IN THE TREATMENT OF MYASTHENIA GRAVIS.
Br Med J. 1935 Mar 9;1(3870):463-5. doi: 10.1136/bmj.1.3870.463.
8
Combined use of neostigmine and ocular motility measurements in the diagnosis of myasthenia gravis.
Arch Ophthalmol. 1982 May;100(5):761-3. doi: 10.1001/archopht.1982.01030030765008.
9
The effect of prostigmin on the basal electromyogram in myasthenia.
Pol Med J. 1970;9(3):730-7.
10
The effect of prostigmin on the basal electromyogram in myasthenia.
Pol Med J. 1970;9(4):932-8.
引用本文的文献
1
Myasthenia Gravis: Novel Findings and Perspectives on Traditional to Regenerative Therapeutic Interventions.
Aging Dis. 2023 Aug 1;14(4):1070-1092. doi: 10.14336/AD.2022.1215.
2
Neuromuscular Weakness and Paralysis Produced by Snakebite Envenoming: Mechanisms and Proposed Standards for Clinical Assessment.
Toxins (Basel). 2023 Jan 6;15(1):49. doi: 10.3390/toxins15010049.
3
Current Treatment of Myasthenia Gravis.
J Clin Med. 2022 Mar 14;11(6):1597. doi: 10.3390/jcm11061597.
4
History of Myasthenia Gravis Revisited.
Noro Psikiyatr Ars. 2020 Nov 7;58(2):154-162. doi: 10.29399/npa.27315. eCollection 2021 Jun.
5
Treatment of Myasthenia Gravis.
Neurol Clin. 2018 May;36(2):311-337. doi: 10.1016/j.ncl.2018.01.011.
6
Perioperative management in myasthenia gravis: republication of a systematic review and a proposal by the guideline committee of the Japanese Association for Chest Surgery 2014.
Gen Thorac Cardiovasc Surg. 2015 Apr;63(4):201-15. doi: 10.1007/s11748-015-0518-y. Epub 2015 Jan 22.
7
Reversal of experimental paralysis in a human by intranasal neostigmine aerosol suggests a novel approach to the early treatment of neurotoxic envenomation.
Clin Case Rep. 2013 Oct;1(1):7-15. doi: 10.1002/ccr3.3. Epub 2013 Jul 24.
8
Acetylcholinesterase inhibitor treatment for myasthenia gravis.
Cochrane Database Syst Rev. 2014 Oct 13;2014(10):CD006986. doi: 10.1002/14651858.CD006986.pub3.
9
Early Treatment with Intranasal Neostigmine Reduces Mortality in a Mouse Model of Naja naja (Indian Cobra) Envenomation.
J Trop Med. 2014;2014:131835. doi: 10.1155/2014/131835. Epub 2014 May 14.
10
Myasthenia gravis: a review.
Autoimmune Dis. 2012;2012:874680. doi: 10.1155/2012/874680. Epub 2012 Oct 31.
Zotero 插件